Stella01wilson
S

7 Artikel veröffentlicht

Endocannabinoid System Targeted Therapeutics Market is projected to be over USD 5 billion by 2030

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions Roots Analysis has announced the...

Contract Regulatory Affairs-Management Services Market for medical devices is estimated to be worth USD 820 million by 2030

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market Roots Analysis is pleased to announce the publication of its recent...

Medical Device Contract Manufacturing Market is estimated to be worth USD 126 Billion in 2030

Over the years outsourcing has become a popular trend among medical device developers, allowing such companies to leverage the expertise / substantial production capabilities of CMOs / CDMOs in order to gain cost and time related benefits Roots Analysis is pleased to announce the publication...

In Vitro ADME Testing Services Market is likely to be worth USD 2.2 billion by 2030

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis has announced the addition of “In Vitro ADME...

Novel Vaccine Delivery Devices Market is estimated to be worth USD 1.5 billion in 2030

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient Roots Analysis is pleased to announce the publication of its recent...

Microbial Contract Biomanufacturing Market is projected to be worth USD 9.3 billion by 2030

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment Roots Analysis has announced the addition of the “Microbial Contract...

Next Generation Immune Checkpoint Inhibitors and Stimulators Market is estimated to be worth USD 12.5 billion in 2030

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune...